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MICU1 is a component of the mitochondrial calcium
uniporter, a multiprotein complex that also includes
MICU2, MCU, and EMRE. Here, we describe a mouse
model of MICU1 deficiency. MICU1/ mitochondria
demonstrate altered calcium uptake, and deletion
of MICU1 results in significant, but not complete,
perinatal mortality. Similar to afflicted patients,
viable MICU1/ mice manifest marked ataxia and
muscle weakness. Early in life, these animals dis-
play a range of biochemical abnormalities, including
increased resting mitochondrial calcium levels,
altered mitochondrial morphology, and reduced
ATP. Older MICU1/ mice show marked, sponta-
neous improvement coincident with improved mito-
chondrial calcium handling and an age-dependent
reduction in EMRE expression. Remarkably, deleting
one allele of EMRE helps normalize calcium uptake
while simultaneously rescuing the high perinatal mor-
tality observed in young MICU1/ mice. Together,
these resultsdemonstrate thatMICU1servesasamo-
lecular gatekeeper preventing calcium overload and
suggests thatmodulating the calcium uniporter could
have widespread therapeutic benefits.INTRODUCTION
Calcium entry into the mitochondria is critical for cellular homeo-
stasis and is believed to modulate bioenergetic capacity and
help determine the threshold for cell death (Balaban, 2009; Orre-
nius et al., 2003). For over 50 years, it has been appreciated that
isolated mitochondria could rapidly take up calcium, using the
large mitochondrial membrane potential across the inner mito-
chondrial membrane as a driving force for the entry of the ion
(Deluca and Engstrom, 1961; Vasington and Murphy, 1962).
Subsequent studies demonstrated that this uptake was highly
selective for calcium (Kirichok et al., 2004). These and otherThis is an open access article undstudies help define the biophysical properties of the inner mito-
chondrial membrane channel, now termed the mitochondrial
calcium uniporter complex. Nonetheless, the molecular compo-
nents of the uniporter complex remained elusive for over five de-
cades. However, in the last several years, rapid progress has
been made, including the molecular identification of a 40-kD in-
ner mitochondrial membrane protein (MCU) as the pore-forming
protein of the uniporter complex (Baughman et al., 2011; De Ste-
fani et al., 2011).
The composition of the uniporter complex is now believed to
contain several additional components beyond the pore-forming
MCU protein. These include the MCU paralog MCUb, a family
of related EF-hand-containing proteins (MICU1, MICU2, and
MICU3), and a small 10-kD protein, EMRE (Foskett and Phili-
pson, 2015; Kamer and Mootha, 2015; Murgia and Rizzuto,
2015). The composition of the uniporter complex appears to
differ between various cell lines and between different tissues;
for instance, the expression of MICU3 appears to be largely
confined to the brain (Plovanich et al., 2013), and the relative ratio
of MCU and MCUb appears to markedly differ in various organs
(Raffaello et al., 2013). These differences in compositionmight, in
turn, be important for the observed tissue-specific differences in
uniporter activity (Fieni et al., 2012).
Although the recent molecular identification of MCU has
provided significant insight into the regulation of mitochondrial
calcium entry, numerous questions persist. Experimental evi-
dence suggests that rates of calcium entry through the uniporter
are sigmoidal, with slow rates of calcium uptake at low extra-
mitochondrial calcium concentrations and faster uptake when
calcium concentrations begin to exceed 10–15 mM (Csorda´s
et al., 1999, 2010; Giacomello et al., 2010; Rizzuto et al., 1998).
This sigmoidal behavior is critical because this endows resis-
tance to calcium overload at resting cytosolic calcium levels
while still allowing the mitochondria to respond to a rise in cyto-
plasmic calcium induced by agonist stimulation. Although such
gating behavior could result from the intrinsic properties of
MCU itself, considerable attention has focused on other compo-
nents of the uniporter complex. Particular emphasis has been
placed on what inhibits calcium uptake at low calcium levels,
providing the necessary gatekeeping functions of the uniporter
and thus preventing the potentially disastrous consequencesCell Reports 16, 1561–1573, August 9, 2016 1561
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of calcium overload. Studies have suggested that both MICU1
(Csorda´s et al., 2013; de la Fuente et al., 2014; Kamer and Moo-
tha, 2014; Mallilankaraman et al., 2012) andMICU2 (Patron et al.,
2014) might mediate this gatekeeping function. To date, most
studies have relied on the behavior of permeabilized cell lines
in which uniporter components were knocked down (Csorda´s
et al., 2013; de la Fuente et al., 2014; Mallilankaraman et al.,
2012; Patron et al., 2014) or used specific cell lines contain-
ing clustered regularly interspaced short palindromic repeats
(CRISPR)-mediated cellular knockouts (Kamer and Mootha,
2014). Analysis of these cellular data employing knockdown
and knockout of MICU1 has, however, often revealed conflicting
results. For instance, the role of MICU1 at high calcium concen-
trations has varied between studies, with some arguing that
knockdown of MICU1 does not alter mitochondrial calcium up-
take following agonist-induced calcium release (Mallilankara-
man et al., 2012). Others have suggested that cells lacking
MICU1 are impaired in this capacity (Csorda´s et al., 2013; Peroc-
chi et al., 2010), whereas still others have demonstrated that the
effects may be determined by the strength of the agonist stimu-
lation (de la Fuente et al., 2014). There are similar ambiguities
with regard to whether genetic inhibition of MICU1 leads to
resting calcium overload, again with some studies arguing that
it does (Mallilankaraman et al., 2012; Patron et al., 2014) and
others suggesting that it does not (Csorda´s et al., 2013; de la
Fuente et al., 2014; Perocchi et al., 2010). It is likely that differ-
ences in experimental approaches, including differences in the
degree of knockdown, as well as differences in the intrinsic
composition of the uniporter complex in the various cell lines em-
ployed might at least partially explain these divergent results.
Further insight into the regulation of uniporter activity has
come from the recent description of a cohort of childrenwho pre-
sented with a range of severe symptoms characterized by pro-
found proximal skeletal muscle weakness accompanied by
neurological features that included chorea, tremors, and ataxia
(Logan et al., 2014). Subsequent genetic analysis identified
that the afflicted children carried loss-of-function mutations in
MICU1 that were inherited in an autosomal recessive fashion.
Initial characterization of fibroblast cell lines derived from pa-
tients and controls were consistent with the hypothesis that
loss of MICU1 leads to mitochondrial calcium overload (Logan
et al., 2014). Although MICU1 deficiency is rare, the clinical
phenotype described in these patients shares features with
other, more common conditions, includingmuscular dystrophies
as well as congenital and mitochondrial myopathies. These en-
tities are often accompanied by mitochondrial dysfunction and
damage. Indeed, mitochondrial calcium overload is being
increasingly viewed as a common final pathway for a wide range
of human pathologies (Abeti and Abramov, 2015; Bhosale et al.,
2015; Martin and McGee, 2014; Santulli et al., 2015; Vallejo-Illar-
ramendi et al., 2014). Most of these conditions, like MICU1 defi-
ciency, have few therapeutic options.
Here, we describe a mouse model in which we have deleted
MICU1. These mice exhibit many of the characteristics recently
observed in patients lacking MICU1 expression. Remarkably,
although the absence of MICU1 leads to high perinatal mortality
and marked abnormalities in young mice, many, but not all, of
these defects improve with time. Older MICU1/ mice also1562 Cell Reports 16, 1561–1573, August 9, 2016have improved mitochondrial calcium-handling parameters,
suggesting an age-dependent remodeling of their uniporter
complex. Consistent with this remodeling, older MICU1/
mice demonstrate a decline in EMRE expression. To further
assess the importance of this decline in EMRE expression, we
generated mice with targeted deletions in the EMRE locus. Sur-
prisingly, EMRE heterozygosity significantly ameliorates the
MICU1/ phenotype. These results clarify themolecular regula-
tion of mitochondrial calcium influx and suggest potential strate-
gies that might have therapeutic benefit in the growing number of
conditions characterized by calcium overload.
RESULTS
MICU1 Deletion Alters Calcium Uptake Rates
In an effort to better understand the molecular function of
MICU1, we generated MICU1/ mice using CRISPR-mediated
methods. Four different founder mice, representing four inde-
pendent genomic targeting events, were generated (Figure S1A).
Each line yielded similar results, and therefore, we have incorpo-
rated data from all four lines. As expected, mitochondria isolated
from this MICU1/ mouse lacked expression of MICU1 protein
(Figure S1B). Next, we asked whether deletion of MICU1 altered
calcium uptake. Wild-type (WT) liver mitochondria loaded with a
calcium-sensitive fluorophore showed little evidence of calcium
uptake when challenged with a low concentration (estimated
free calcium concentration of 0.5 mM) of extra-mitochondrial cal-
cium (Figure 1A). In contrast, the absence of MICU1 expression
led to a significantly increased rate of calcium uptake under
these conditions (Figures 1A and 1B). In the setting of higher con-
centrations of extra-mitochondrial calcium (estimated free cal-
cium concentration of 16 mM), the absence of MICU1 appeared
to reduce the rate of mitochondrial calcium entry (Figures 1C and
1D). Similar alterations in calcium uptake were observed in
MICU1/ mitochondria isolated from other tissues such as
brain (Figures S1C and S1D). Thus, in purified mitochondria,
the absence of MICU1 expression augments calcium uptake
rates at low calcium concentrations and inhibits uptake rates
at high calcium concentrations.
We further validated these properties using mouse embryonic
fibroblasts (MEFs) derived from embryos of MICU1/ mice or
their WT littermates. As observed in isolated mitochondria,
MICU1/ MEFs lacked discernable MICU1 expression (Fig-
ure 1E). As seen with isolated mitochondria, permeabilized WT
MEFs showed little uptake of calcium at low calcium concentra-
tions (Figure 1F). In contrast to WT MEFs, MICU1/ MEFs
displayed increased rates of calcium uptake under these same
conditions (Figures 1F and 1G). When MICU1 expression was
reconstituted in MICU1-deficient cells (Figure 1E), WT calcium
uptake properties were restored (Figures 1F and 1G).
MICU1/ Mice Develop Severe Neurological and
Myopathic Defects
Next, we sought to characterize the phenotype of mice lacking
MICU1 expression. Breeding of heterozygous MICU1+/ mice
resulted in significantly fewer MICU1/ mice than expected.
Analysis of over 1,300 births demonstrated that only one in
roughly every six or sevenMICU1/ animals was able to survive
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Figure 1. MICU1 Regulates Calcium Uptake
(A) Representative extra-mitochondrial calcium
traces with WT or MICU1/ liver mitochondria
using the calcium indicator Fluo-4. The estimated
free calcium concentration is 0.5 mM.
(B) Quantification of calcium uptake rates in liver
mitochondria at low (0.5 mM) extra-mitochondrial
calcium concentration (n = 5 per genotype, data
are represented as mean ± SD).
(C) Representative extra-mitochondrial calcium
traces with WT or MICU1/ liver mitochondria at
high calcium concentration (estimated at 16 mM)
using Calcium Green-5N as an indicator.
(D) Quantification of calcium uptake rates in liver
mitochondria at high (16 mM) extra-mitochondrial
calcium concentration (n = 5 per genotype, data
are represented as mean ± SD).
(E) Western blot of MEFs isolated from WT and
MICU1/ embryos that were stably transduced
with either an empty vector or with a vector en-
coding an epitope-tagged MICU1 construct. Pro-
tein levels of MICU1, MCU, and tubulin as a
loading control are shown.
(F) Representative traces of cytosolic calcium
measurements in permeabilized cells exposed to a
pulse of approximately 0.5 mM free calcium.
Shown are WT MEFs infected with a vector con-
trol, MICU1/ MEFs with a vector control, or
MICU1/ MEFs reconstituted with a lentivirus
encoding an epitope-tagged MICU1.
(G) Quantification of calcium uptake rates at low
calcium concentration (0.5 mM) in permeabilized
MEFs (n = 3 per condition, mean ± SD).
**p < 0.01, *p < 0.05. See also Figure S1.beyond the first post-natal week (Figure 2A). In contrast, exam-
ination of litters from late embryogenesis to immediately after
birth demonstrated that, although late-stageMICU1/ embryos
were slightly smaller than WT littermates (Figure 2B), there ap-
peared to be no embryonic selection against MICU1/ progeny.
Indeed, whenwe analyzed a total of 60 late-stage embryos/post-
natal day 1 (P1) pups, we observed the precise number of mice
expected in each genotype (15 WT, 30 MICU1+/, and 15
MICU1/ mice, equivalent to a 25% frequency of knockouts).
In contrast, although it is not unusual for some pups to die inCell Rethe first few days after birth, when we as-
sessed the litters of MICU1+/ crosses,
96 of 138 spontaneous perinatal deaths
(70%) were of the MICU1/ genotype.
Thus, although MICU1 expression ap-
pears to be largely dispensable for devel-
opment, the absence of MICU1 results in
a high, but not complete, perinatal death
rate. These observations contrast slightly
from a very recent report demonstrating
that MICU1 deletion resulted in 100%
perinatal mortality (Antony et al., 2016).
In that report, the authors observed that
MICU1/ mice exhibited a decreased
number of specific brainstem neurons
known to regulate respiration. Althoughthis decrease was just a trend, other models where deletion of
critical mitochondrial proteins leads to perinatal mortality have
also shown impaired neuronal innervation of the diaphragm
(Nguyen et al., 2014). In that context, we also observed amodest
trend for a decreased number of cervical motor neurons required
for respiration in MICU1/ late-term embryos (Figures S2A and
S2B), although it remains unclear to what degree this contributed
to the high rate of perinatal death.
At 1 week of age, surviving MICU1/ mice appeared under-
developed and smaller and weighed roughly 50% less thanports 16, 1561–1573, August 9, 2016 1563
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Figure 2. Mice Lacking MICU1 Develop Multiple Neurologic and Myopathic Defects
(A) Expected and observed number of MICU1+/+, MICU1+/, and MICU1/ mice surviving over 1 week. The actual number of expected and observed mice is
shown above each column from a total of over 1,300 offspring.
(B) E20 littermates demonstrating the appearance of a WT and slightly smaller MICU1/ embryo.
(C) Appearance of WT and MICU1/ mice at 1 week of age.
(D) Body weight for 14- to 18-day-old male (n = 12) and female (n = 6) WT and MICU1/ mice. Data are represented as mean ± SD.
(E) Cerebellar function in 4-week-old WT and MICU1/ mice assessed by performance on a balance beam and measured as cumulative number of foot slips
(n = 4 mice per genotype, mean ± SD).
(F and G) Cerebellar architecture in 12-day-old WT mice (F) or MICU1/ mice (G). Arrows denote the outer granular layer.
(legend continued on next page)
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their WT littermates (Figures 2C and 2D). Young MICU1/
mice, like children bearing mutations in MICU1, appear to suf-
fer from ataxia. Functional analysis revealed that 1-month-old
MICU1/ mice had severely impaired performance on a bal-
ance beam (Figure 2E). A closer histological examination of
the cerebellum revealed abnormal persistence of the outer
granular layer in 12-day-old mice lacking MICU1 expression
(Figures 2F and 2G). In addition, the overall cerebellum of
young MICU1/ mice appeared underdeveloped (Figure S2C).
Consistent with their observed neurological defects, MICU1/
mice also exhibited alterations in the post-natal arborization of
Purkinje cells (Figures 2H and 2I). Given that patients lacking
MICU1 develop proximal myopathies, we also assessed mus-
cle strength in MICU1/ mice. Histologically, we did not
observe any evidence of central nuclei or marked changes in
the abundance of fast and slow fibers in the skeletal muscle
of MICU1/ mice (Figures S2D–S2F). Similarly, histochemical
enzyme assays of succinate dehydrogenase (SDH) and cyto-
chrome c oxidase (COX) activity revealed no significant differ-
ences between WT and MICU1/ muscle fibers, except that,
consistent with overall body size, the MICU1/ fibers were
considerably smaller (Figures S2G and S2H). Nonetheless,
4-week-old MICU1/ mice were markedly impaired in an in-
verted grid test of skeletal muscle function (Figure 2J) as well
as in their performance in a wire hang test, another measure
of skeletal muscle strength and coordination (Figure S2I).
Thus, these mice appear to exhibit many of the neurological
and myopathic defects observed in MICU1-deficient patients.
We also, however, observed additional properties not formally
assessed in human patients. Although analysis of splenic and
thymic T cell maturation revealed no discernable alterations
(Figures S3A–S3F), the numbers of splenic B cells were mark-
edly reduced in MICU1/ mice (Figures 2K–2M; Figures S3G–
S3I). This decrease in overall B cell number was consistent with
an observed increase in cell death observed in MICU1/ B
cells (Figures S3J–S3L). The more pronounced effects
observed in B cells, compared with T cells, may reflect intrinsic
differences in MICU1 expression between these two cell types
(Figure S3M).
MICU1 Deletion Leads to Calcium Overload
Next, we sought to better understand the biochemical basis
underlying the various phenotypic alterations observed in
MICU1/ mice. Given our observations that, depending on
the calcium concentration, MICU1 deletion has either positive
or negative effects on calcium uptake, the net effect on resting
mitochondrial calcium levels was difficult to predict a priori.
Therefore, we first sought to directly measure in situ matrix mito-
chondrial calcium levels. This analysis revealed that mitochon-
dria from young MICU1/ mice had an approximate 1.5-fold in-
crease in their resting levels of mitochondrial matrix calcium(H and I) Calbindin staining demonstrating Purkinje cell morphology in 12-day-ol
(J) Assessment of muscle strength using an inverted grid test at 4 weeks of age
(K and L) Representative fluorescence-activated cell sorting (FACS)-based asses
SSC-A, side scatter area.
(M) Mean B cell percentage in spleens of 2- to 3-week-old WT and MICU1/ m
**p < 0.01, *p < 0.05. See also Figures S2 and S3.(Figure 3A). This argues that the predominant in vivo effect of
MICU1 is to function as a gatekeeper because, in the absence
of this molecule, mitochondria exhibit tonic calcium overload.
A number of abnormalities have previously been associated
with calcium overload, including alterations in mitochondrial
morphology and increased generation of reactive oxygen spe-
cies (ROS) (Peng and Jou, 2010). Consistent with these past ob-
servations in other systems, electron micrographs revealed that
MICU1/ mice had marked alterations in skeletal muscle mito-
chondrial morphology (Figures 3B and 3C). Similar alterations
were seen with mitochondria in the brain (Figure S4A). In addi-
tion, we noted that ATP levels were also significantly reduced
in MICU1/ skeletal muscle (Figure 3D), although alterations
in resting ATP levels were not as evident in the brain (Figure S4B).
Another common hallmark of mitochondrial dysfunction is a rise
in lactate levels, a feature also evident in the skeletal muscle of
MICU1/ mice (Figure 3E). We saw a similar increase in blood
lactate levels (Figure S4C). To assess tissue ROS levels, we
took advantage of our previous observations of B cell defects
in MICU1/ mice (Figure 2M). Using the redox-sensitive fluoro-
phore 2’,7’-dichlorofluorescin diacetate (DCFDA), we noted a
significant increase in the ROS levels observed in MICU1/ B
cells (Figures 3F and 3G). A similar elevation in ROS levels was
also seen in thymus-derived T cells (Figures S4D and S4E). Mito-
chondrial uncoupling abrogated the difference in ROS levels be-
tween WT and MICU1/ cells, consistent with a mitochondrial
source for the elevated levels of ROS observed inMICU1/ cells
(Figures S4F and S4G).
Age-Dependent Improvement in MICU1/ Mice
Although the survival and appearance of newborn and young
MICU1/ mice was markedly impaired, we noted that surviving
MICU1/ mice appeared to improve over time (Figure 4A). This
improvement was evident in appearance and overall body
weight. Although MICU1/ mice remained smaller than their
WT littermates, these differences narrowed considerably as the
animals aged (Figure 4B). With this phenotypic improvement,
we noted that differences in resting calcium, ATP, and muscle
lactate were no longer significantly different between older WT
and MICU1/ mice, although a trend toward increased resting
calcium, decreased resting ATP, and increased lactate remained
(Figures 4C–4E). Similarly, the differences in B cell abundance
and ROS levels observed in young MICU1/ mice were no
longer evident as these animals aged (Figures 4F–4H and S5A–
S5C). Histological assessment of the cerebellum of MICU1/
mice revealed that previous abnormalities, such as a persistent
outer granular layer, resolved in the brains of older MICU1/
mice (Figures 4I and 4J). This suggests that MICU1/ mice
experience a developmental delay, rather than a complete block,
of this post-natal cerebellar process. Althoughmany of the histo-
logical and biochemical parameters improved in the olderd WT (H) and MICU1/ (I) cerebellum.
(n = 4 mice per genotype, mean ± SD).
sment of splenic B cell (CD45R+) abundance in WT (K) and MICU1/ (L) mice.
ice (n = 6 per genotype, mean ± SD).
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Figure 3. MICU1-Deficient Mice Develop Mitochondrial Defects
(A) Relative levels of mitochondrial matrix calcium in WT and MICU1/ mice. Mitochondria were isolated from the brains of 14- to 18-day-old mice (n = 3 per
genotype, mean ± SD).
(B and C) Electron micrograph of WT (B) and MICU1/ (C) skeletal muscle at 9 days of age. Arrows indicate mitochondria.
(D) Relative skeletal muscle ATP levels in 14- to 18-day-old WT and MICU1/ mice (n = 5 mice per genotype, mean ± SD).
(E) Skeletal muscle lactate levels in 12- to 16-day-old WT and MICU1/ mice (n = 5 mice per genotype, mean ± SD).
(F) Representative levels of ROS as assessed by DCF fluorescence in immunoglobulin M (IgM)-positive B cells from WT and MICU1/ mice.
(G) Mean DCF fluorescent intensity in IgM-positive B cells obtained from 2- to 3-week-old WT and MICU1/ mice (n = 5 per genotype, mean ± SD).
**p < 0.01, *p < 0.05. See also Figure S4.MICU1/ mice, we did, however, continue to see persistent
functional defects in both neurological and skeletal muscle func-
tion (Figures S5D and S5E). In addition, as these animals aged,
new abnormalities arose. For instance, electron micrographs
of skeletal muscle revealed the presence of tubular aggregates
(Figure 4K). Interestingly, in humans, this relatively rare
myopathic abnormality has been recently described to result
from alterations in skeletal muscle calcium handling because
of patients inheriting dominant mutations in stromal interaction
molecule 1 (STIM1), an endoplasmic reticulum (ER) calcium
sensor (Bo¨hm et al., 2013).
In an effort to explain why some of the parameters improved in
MICU1/ mice as they aged, we re-evaluated calcium uptake
parameters from mitochondria derived from the liver of older1566 Cell Reports 16, 1561–1573, August 9, 2016MICU1/ animals. Although the defects in calcium uptake at
high calcium concentrations remained essentially unchanged
(Figures S5F and S5G), we noted that the loss of gatekeeping
function at low calcium concentrations was now less marked
(compare Figures 5A and 5B to Figure 1A). This suggested that
some age-dependent remodeling of the uniporter complex
might have occurred. We therefore examined the levels of
MCU and EMRE proteins in the livers of young (2-week-old)
and old (7-month-old) WT and MICU1/ mice. We noted that,
at 2 weeks of age, surviving MICU1/ animals had similar levels
of MCU as WT animals but had a reduced EMRE-to-MCU
expression ratio (Figure 5C). Interestingly, at 7 months of age,
the EMRE/MCU expression ratio had fallen even lower in these
now phenotypically improved older MICU1/ mice.
EMRE Heterozygosity Rescues MICU1/ Mice
Previous observations with EMRE knockdown in cultured cells
suggest that EMRE functions as a scaffold for MCU and is
required to maintain channel opening (Kova´cs-Bogda´n et al.,
2014; Sancak et al., 2013; Vais et al., 2016). Our observation
that reduced expression of EMRE in older MICU1/mice corre-
lated with phenotypic improvement suggested that MICU1/
mice might remodel their uniporter complex by reducing EMRE
expression. Such remodeling would likely limit uniporter opening
and, hence, help prevent calcium entry and in vivo calcium over-
load. To test this hypothesis, we reasoned that genetically
reducing EMRE expression might therefore provide a benefit in
the setting of MICU1 deficiency. Using CRISPR-mediated
methods, we generated additional mice containing targeted de-
letions in the EMRE locus located on chromosome 15 of the
mouse (Figure S6A). We crossed MICU1+/EMRE+/ mice to
find out whether EMRE deficiency could rescue the perinatal
mortality of MICU1/ mice. As expected, only a small fraction
of MICU1/EMRE+/+ mice survived into the first week (Fig-
ure 6A). Similarly, to date, we have not observed any surviving
MICU1/EMRE/ mice; however, in this mixed genetic back-
ground, we were able to generate MICU1+/+EMRE/ mice
(Figure S6B). Mice lacking EMRE but having wild-type MICU1
appeared to have normal body weight and exhibited no evi-
dence of ataxia or defects in skeletal muscle function (Figures
S6C–S6E).
Remarkably, MICU1/ EMRE+/ mice were observed at
nearly the expected frequency at weaning (Figure 6A). We
saw a similar capacity to rescue MICU1-deficient animals using
a second, independent, CRISPR-generated EMRE-deficient
mouse line (Figure S6A). Interestingly, young MICU1/
EMRE+/ mice had reduced hepatic levels of EMRE expression
compared with MICU1/ mice (Figure 6B). The overall appear-
ance and weight of the MICU1/ EMRE+/ mice was indistin-
guishable from WT mice (Figures 6C and S6F). Based on this
genetic rescue, we next asked whether, in the context of
MICU1 deletion, deleting one allele of EMRE resulted in
improved calcium uptake. We observed that liver mitochondria
from young MICU1/ EMRE+/ mice still had slightly impaired
gatekeeping function at low extra-mitochondrial calcium levels
(Figure 6D). Under these low-calcium conditions, MICU1/
EMRE+/ mitochondria had roughly 2-fold higher rates of cal-
cium uptake than WT mitochondria (Figure 6E). Nonetheless,
this defect was markedly reduced compared with the nearly
6-fold difference observed previously in MICU1/mitochondria
(Figure 1B). At high calcium concentrations, a situation in which
MICU1/ mitochondria demonstrate reduced rates of calcium
uptake, EMRE heterozygosity resulted in a modest but further
reduction in this property (compare Figures 6F and 6G with Fig-
ure 1D). These results are consistent with a role for EMRE in
maintaining channel opening because, in the absence of
MICU1 expression, deletion of one allele of EMRE reduced
EMRE expression and resulted in reduced calcium uptake at
both low and high extra-mitochondrial calcium levels. Interest-
ingly, by itself, EMRE heterozygosity appeared to have no signif-
icant effect on hepatic EMRE levels or on calcium uptake (Fig-
ures S6G–S6I). This suggests that, in the setting of wild-type
levels of the other uniporter complex components, one allele ofEMRE is sufficient to maintain the required level of protein
expression. We cannot, however, exclude the possibility that
the reason why the effects of deleting one allele of EMRE is
only evident in the context of MICU1 deletion relates to the
recent observation that EMRE’s activity can be regulated by a
rise in matrix calcium levels (Vais et al., 2016), a situation that
presumably occurs in MICU1/, but not WT, mitochondria.
Consistent with the observed reduction in calcium uptake at
low calcium levels, brain matrix calcium levels appeared to be
similar between WT and MICU1/ EMRE+/ mitochondria iso-
lated from youngmice (compare Figure 6H with Figure 3A). Skel-
etal muscle mitochondrial morphology was also apparently
normalized in these mice (Figure 6I). Similarly, although skeletal
muscle ATP levels trended slightly lower than seen in WT mice,
this differencewas not statistically significant (compare Figure 6J
with Figure 3D). Young MICU1/ EMRE+/ animals also ex-
hibited age-appropriate cerebellar morphology (Figure 6K) and
an amelioration of the observed B cell alterations (Figures S6J–
S6O). Moreover, compared with MICU1/ mice (Figure 2E),
MICU1/ EMRE+/ mice exhibited improvement in their perfor-
mance on the balance beam, although they were still impaired
compared withWT animals (Figure 6L). Similarly, skeletal muscle
strength was still impaired in the MICU1/ EMRE+/ mice,
although, again, these animals performed slightly better than
MICU1/ animals (Figure S6P).
DISCUSSION
Our results significantly clarify the in vivo function of MICU1. In
particular, using isolated WT and MICU1/ mitochondria, we
demonstrate that the absence ofMICU1 increasesmitochondrial
calcium uptake rates at low calcium concentrations and reduces
calcium entry rates at high calcium concentrations. Nonetheless,
although these changes in gating properties could theoretically
lead to either increased or decreased mitochondrial calcium
levels, our data suggest that, in vivo, the primary function of
MICU1 is to function as a molecular gatekeeper. In particular,
in the absence of MICU1, mitochondrial matrix calcium levels
are increased, and the deleterious consequences of this in-
crease are evident in a wide range of abnormalities, including al-
terations in mitochondrial morphology, changes in ATP, and
elevation of lactate levels. Further proof of the loss of gate-
keeping function comes from analyzing animals bearing the
MICU1/EMRE+/ genotype. Compared with MICU1/ mito-
chondria, the mitochondria derived from these animals have
reduced EMRE expression and slower rates of calcium uptake
at both low and high extra-mitochondrial calcium concentra-
tions. Thus, in the setting of MICU1 deletion, deletion of one
allele of EMRE appears to restrict uniporter opening, thereby
helping to prevent MICU1-induced calcium overload. The obser-
vation that EMRE heterozygosity also markedly improves the
overall survival of MICU1/ mice provides strong genetic proof
that the primary in vivo function of MICU1 is to serve as a gate-
keeper of the uniporter complex.
Our data suggest that MICU1 is not required during embryo-
genesis. However, immediately after birth, the absence of
MICU1 induces high rates of perinatal mortality, with themajority
of MICU1/ mice dying in the first 48 hr. Indeed, based on aCell Reports 16, 1561–1573, August 9, 2016 1567
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Figure 4. Surviving MICU1-Deficient Mice Improve over Time
(A) Appearance of WT and MICU1/ mice at 8 months of age.
(B) Bodyweight of 3- to 4-month-oldmale and femaleWT andMICU1/mice (n = 7WTmale and n = 4WT femalemice; n = 9MICU1/male and n = 4MICU1/
female mice). Data are represented as mean ± SD.
(C) Relative levels ofmitochondrial matrix calcium inWT andMICU1/mice.Mitochondria were isolated from the brains of 7-month-oldmice (n = 6 per genotype,
mean ± SD). ns, not significant.
(legend continued on next page)
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Figure 5. Older MICU1-Deficient Mice
Exhibit Improved Calcium Uptake and
Reduced EMRE Expression
(A) Representative extra-mitochondrial calcium
traces with WT or MICU1/ liver mitochondria
from 7-month-old mice using the calcium indicator
Fluo-4. The estimated free calcium concentration
is 0.5 mM.
(B) Quantification of calcium uptake rates in liver
mitochondria from 7-month-old mice at low
(0.5 mM) extra-mitochondrial calcium concentra-
tion (n = 3 per genotype, data are represented as
mean ± SD).
(C) Western blot of MCU and EMRE protein levels
in liver mitochondria obtained from four pairs of
2-week-old WT and MICU1/ mice.
(D) Western blot of MCU and EMRE protein levels
in liver mitochondria obtained from four pairs of
7-month-old WT and MICU1/ mice. The mito-
chondrial protein COX4 is shown as a loading
control.large number of births from four independent founder lines, we
estimate that, in a C57BL/6N background, only one in six to
seven MICU1/ mice survive beyond 1 week. In contrast, while
this manuscript was under review, another group reported that
MICU1 deletion resulted in complete perinatal mortality (Antony
et al., 2016). These survival differences might relate to subtle dif-
ferences in the animal facilities or, more likely, to the knownmito-
chondrial differences between C57BL/6J and C57BL/6N sub-
strains (Nicholson et al., 2010; Toye et al., 2005). Remarkably,
our mice that did survive past 1 week function surprisingly well
and actually appear to improve with time. We have currently
observed MICU1/ mice up to 1 year of age, and the only addi-
tional phenotype that has emerged is the appearance of chorea-
like movements (Movie S1), a feature seen in human patients as
well (Logan et al., 2014). This would suggest that the absence of
MICU1 expression is particularly critical immediately after birth.
This may relate to the essential role of the mitochondria in the
transition from the relatively hypoxic environment of the placenta(D) Relative skeletal muscle ATP levels in 7-month-old WT and MICU1/ mice (n = 5 mice per genotype, m
(E) Skeletal muscle lactate levels in 7-month-old WT and MICU1/ mice (n = 5 mice per genotype, mean ±
(F and G) Representative FACS-based assessment of splenic B cell (CD45R+) abundance in 7-month-old W
(H) Representative levels of ROS as assessed by DCF fluorescence in IgM-positive B cells from 7-month-ol
(I and J) Cerebellar architecture in 6-week-old WT (I) or MICU1/ (J) mice. Arrows indicate the normal-app
(K) Electron micrograph of MICU1/ skeletal muscle at 7 months of age. Arrows indicate tubular aggregate
**p < 0.01, *p < 0.05. See also Figure S5.
Cell Reto the oxygenated environment found af-
ter birth. We do not have a clear under-
standing of why the functional defects in
the surviving MICU1/ mice seem to be
most pronounced in skeletal muscle and
the brain. In that regard, additional
studies are needed to understand these
tissue-specific effects. Comparisons of
calcium uptake in different tissues, partic-
ularly between excitatory tissues such asskeletal muscle, brain, and heart versus non-excitatory tissues
such as liver and kidney, might therefore be informative.
The gradual improvement of MICU1/ mice over time
perhaps suggests that mitochondria are capable of undergoing
some level of functional remodeling. Such remodeling has
been demonstrated recently in animal models in which MCU
activity is reduced (Rasmussen et al., 2015) andmay also explain
the more pronounced phenotype in mouse models of acute
MCU deletion in adult animals (Kwong et al., 2015; Luongo
et al., 2015) when contrasted to models in which MCU is deleted
or inhibited throughout embryogenesis (Holmstro¨m et al., 2015;
Pan et al., 2013; Rasmussen et al., 2015). In the case of
MICU1 deletion, this remodeling appears to involve alterations
in the expression ratio of MCU to EMRE. It will be interesting
to discern whether this remodeling represents some form of
retrograde signaling from the mitochondria to the nucleus.
There is increasing evidence of the importance of retrograde
signaling whereby damaged or stressmitochondria emit a poorlyean ± SD).
SD).
T (F) and MICU1/ (G) mice.
d WT and MICU1/ mice.
earing outer granular layer.
s.
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Figure 6. EMRE Heterozygosity Ameliorates MICU1 Deficiency
(A) Percentage of observed and expected MICU1-deficient mice surviving past 1 week with either EMRE+/+, EMRE +/, or EMRE/ genotype status. The actual
number of expected and observed mice from MICU1+/EMRE+/ crosses is shown above each column.
(legend continued on next page)
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characterized signal that elicits a protective nuclear response
(Haynes et al., 2013). In that regard, it is of interest to note that
some previous studies have implicated calcium as a mediator
of the mammalian retrograde response (Biswas et al., 1999).
Finally, there is increasing realization that mitochondrial cal-
cium overload might be a final common pathway in a multitude
of disease conditions, including various myopathies, certain
neurodegenerative diseases, models of heart failure, and
ischemic tissue injury (Abeti and Abramov, 2015; Bhosale
et al., 2015; Martin and McGee, 2014; Santulli et al., 2015; Val-
lejo-Illarramendi et al., 2014). Therefore, strategies that modulate
mitochondrial calcium uptake might have wide therapeutic po-
tential. The demonstration here that modulating EMRE expres-
sion is capable of markedly improving the overall survival as
well as the biochemical, neurological, and myopathic phenotype
of MICU1/ mice suggests that efforts to modulate the uni-
porter complex might be an effective therapeutic avenue for
the growing number of disease states characterized by calcium
overload.
EXPERIMENTAL PROCEDURES
Generation ofMICU1 andEMREKnockoutMice by the CRISPR/Cas9
Method
TheMICU1 and EMRE knockoutmice were generated using the CRISPR/Cas9
method as reported previously (Wang et al., 2013). Briefly, two single guide
RNAs (sgRNAs) were designed to target each gene, one near the translation
initiation codon (ATG) and the other one further downstream within the same
exon. Specifically, the nucleotide sequences for these sgRNAs were as fol-
lows: MICU1-sgRNA 1, TGTTAAGACGAAACATCCTG (reverse orientation);
MICU1-sgRNA 2, TCTGCAGTGACTGCAAGTAC; EMRE-sgRNA 1, GGAG
CTGGAGATGGCGTCCA; and EMRE-sgRNA 2, GCCTGGGTTGCAGTTC
GACC. These sequences were cloned into a sgRNA vector using OriGene’s
gRNA cloning services andwere then used as templates to synthesize sgRNAs
using theMEGAshortscript T7 kit (Life Technologies). Cas9mRNAwas in vitro-
transcribed from plasmidMLM3613 (Addgene, #42251) using themMESSAGE
mMACHINE T7 Ultra kit (Life Technologies). For microinjection, Cas9 mRNA
(100 ng/ml) was mixed with either one or both sgRNA(s) for each gene
(20 ng/ml of each sgRNA) and then microinjected into the cytoplasm of fertil-
ized eggs collected from either C57BL/6N inbred (MICU1) or B6CBAF1/J F1
(EMRE) hybrid mice. The injected zygotes were cultured overnight in M16 me-
dium at 37C in 5% CO2. The next morning, embryos that had reached the
two-cell stage of development were implanted into the oviducts of pseudo-
pregnant foster mothers (Swiss Webster, Taconic Farm). The mice born to
the foster mothers were genotyped using PCR and DNA sequencing.(B) Western blot of MCU and EMRE protein levels in liver mitochondria obtaine
chondrial protein COX4 is shown as a loading control.
(C) Appearance of 14-day-old WT, MICU1/, and MICU1/EMRE+/ mice.
(D) Representative extra-mitochondrial calcium traces for WT and MICU1/EMR
calcium concentration is 0.5 mM.
(E) Quantification of calcium uptake rates in WT (n = 5) and MICU1/EMRE+/
resented as mean ± SD.
(F) Representative extra-mitochondrial calcium traces for WT and MICU1/EM
approximate free calcium concentration is 16 mM.
(G) Quantification (mean ± SD) of calcium uptake rates in WT (n = 5) and MICU1
(H) Relative matrix calcium levels in mitochondria isolated from the brains of 2- t
(I) Electron micrograph of skeletal muscle in a 17-day-old MICU1/EMRE+/ m
(J) Relative ATP levels in the skeletal muscle of 2- to 3-week-old WT (n = 7) and
(K) Cerebellar histology of 16-day-old MICU1/EMRE+/ mice. Arrows indicate
(L) Cerebellar function in 4-week-oldWT andMICU1/EMRE+/mice assessed b
slips (n = 4 mice per genotype, mean ± SD).
**p < 0.01, *p < 0.05. See also Figure S6.Mice
The MICU1 mice were maintained on a C57BL/6N or C57BL/6NxJ F1 back-
ground, and experimental mice were obtained by breeding themice using het-
erozygous crosses. Genotyping for MICU1 was performed using the following
primers: 50-CTGAGGCCAATTAACTGC-30 (forward) and 50-GACACGAC
TAGCTGATAAACCT-30 (reverse). MICU1 heterozygous mice were bred to
EMRE heterozygous mice (B6CBAF1/J 3 CD-1 or C57BL/6N) to generate
double-heterozygous breeders. Genotyping for EMRE was performed using
the following primers: 50-ACCGGCATACGAATGCGTGCTC-30 (forward) and
50-ACCGGCCTCAATCCCTTCGTC-30 (reverse). All animal studies were done
in accordance with and approval of the National Heart, Lung, and Blood Insti-
tute (NHLBI) Animal Care and Use Committee.
Cell Culture
MEFs were prepared using standard methods from embryonic day 12 (E12)–
E14 embryos resulting from MICU1 heterozygous breeders. MEFs were
cultured in growth medium consisting of DMEM (Invitrogen) supplemented
with 15% fetal bovine serum (FBS), 50 U/ml penicillin, and 50 mg/ml strepto-
mycin. An epitope-tagged expression vector encoding MICU1 was generated
using a C-terminal FLAG epitope in-frame with MICU1 derived from wild-type
MEF cDNA. The construct was inserted into pCMV-Tag 4A (Stratagene) using
the following primers: 50-CGC GGA TCC ATG TTT CGT CTT AAC ACC CTT
TCT GCG-30 and 50-GCA TGT GAT ATC TTT GGG CAG AGC AAA GTC CCA
GGC-30. The construct was then inserted into the lentiviral expression vector
pLVX-puro (Clontech Laboratories) by using the following primers: 50-TAG
AAT TAT CTA GAG TCG CGG GAT CCG ACT CAC TAT AGG GCG AAT
TGG G-30 and 50-CAG ATC TCG AGC TCA AGC TTC GAT TAA CCC TCA
CTA AAG GGA ACA AAA GC-30. Lentiviruses were produced in 293T cells
and concentrated by ultracentrifugation by standard methods. MEFs were in-
fected with a lentivirus expressing epitope-taggedMICU1 or empty pLVX vec-
tor at an estimated MOI of 0.5 and subsequently selected with puromycin. All
constructs were verified by DNA sequencing.
Mitochondrial Isolation
Mitochondria were isolated by standard differential centrifugation protocol.
Tissueswere first minced in isolation buffer (225mMmannitol, 75mMsucrose,
5 mM 3-(N-morpholino)propanesulfonic acid (MOPS), 0.5 mM EGTA, 2 mM
taurine, pH adjusted to 7.25) and then homogenized using a Glas-Col homog-
enizer at 1,800 rpm for 8–12 strokes. The mixture was centrifuged for 5 min at
5003 g, and the supernatant was removed and centrifuged again. The super-
natant was then centrifuged at 11,0003 g for 5 min to pellet the mitochondria,
which were washed once more with isolation buffer and resuspended. Protein
content was measured using a bicinchoninic acid assay (BCA) protein assay
(Thermo Scientific).
Intra-mitochondrial Calcium Levels
Measurement of mitochondrial Ca2+ content was performed as described pre-
viously, with minor adjustments as delineated below (Pan et al., 2013). In brief,d from 2-week-old WT, MICU1/, and MICU1/EMRE+/ mice. The mito-
E+/ liver mitochondria using the calcium indicator Fluo-4. The estimated free
liver mitochondria (n = 7) at low calcium concentration (0.5 mM). Data are rep-
RE+/ liver mitochondria using the calcium indicator Calcium Green-5N. The
/EMRE+/ liver mitochondria (n = 7) at high calcium concentration (16 mM).
o 3-week-old WT (n = 6) and MICU1/EMRE+/ (n = 6) mice (mean ± SD).
ouse. Arrows indicate normal-appearing mitochondria.
MICU1/EMRE+/ (n = 10) mice (mean ± SD).
the normal-appearing outer granular layer.
y performance on a balance beam andmeasured as cumulative number of foot
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brain mitochondria were isolated as described above in the presence of 3 mM
Ru360 (Calbiochem) and washed in isolation buffer without EGTA. Mitochon-
dria were pelleted and diluted in 0.6 N HCl, homogenized, and sonicated.
Samples were heated for 30 min at 95C and then centrifuged for 5 min at
10,0003 g. The supernatants were recovered, and the Ca2+ content in the su-
pernatants was determined spectrophotometrically using the O-Cresolphtha-
lein Complexone calcium assay kit (Cayman Chemical). Only samples that
fell within the range of the standard curve were included for analysis, and all
values were normalized to the calcium levels observed in WT mitochondria.
Calcium Uptake Assay
Calcium uptake in mitochondria and MEFs was assayed similarly to what has
been described previously (Kamer and Mootha, 2014). Briefly, isolated mito-
chondria and MEFs were resuspended in a buffer containing 125 mM KCl,
2mMK2HPO4, 10 mMEGTA, 1mMMgCl2, 20mMHEPES (pH 7.2), 5mMgluta-
mate, and 5 mMmalate. For MEFs, 0.004% digitonin was added to permeabi-
lize the cells. The fluorescent cell-impermeable Ca2+ indicator Fluo4 (high-af-
finity, used for low extra-mitochondrial calcium conditions, final concentration
1 mM, Thermo Fisher) or Calcium Green-5N (low-affinity, used for high extra-
mitochondrial conditions, final concentration 1 mM, Thermo Fisher) was added
to the buffer. Fluorescence was measured at 506-nm excitation and 532-nm
emission on an Omega plate reader. Experiments were initiated by injecting
5 mM or 25 mM CaCl2, resulting in an approximate free calcium concentration
of 0.5 mM or 16 mM free [Ca2+], respectively. Calcium uptake curves were
normalized to baseline and maximum, and the relative rate of calcium uptake
was calculated as the absolute value of the slope from linear regression fit
in the linear range of the fluorescent signal (80–300 s at low [Ca2+] and
40–110 s at high [Ca2+]). Relative rates of calcium uptake were normalized to
the WT.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one movie and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.07.011.
AUTHOR CONTRIBUTIONS
J.C.L., J.L., K.M.H., S.M., R.J.P., and M.M.F. performed the experiments. Z.Y.
and C.H. helped with the pathological analysis. D.A.S. performed the neuro-
logical and skeletal muscle phenotyping. C.L. constructed the mouse models.
E.M. and T.F. conceived the project. J.C.L. and T.F. wrote the manuscript.
ACKNOWLEDGMENTS
We are grateful to Michele Allen for help with mouse phenotyping; Erin Stem-
pinski, Camron Keshavarz, and Christopher Bleck for help with electronmicro-
scopic analysis; and Jeffrey Culver at the Sanford-Burnham Orlando Metabo-
lomics Core for skeletal muscle lactate measurements. This work was
supported by Intramural NIH funds, a Leducq Transatlantic Network grant
(to T.F.), and a PRAT postdoctoral fellowship from NIGMS (to J.C.L.).
Received: March 3, 2016
Revised: March 24, 2016
Accepted: July 3, 2016
Published: July 28, 2016
REFERENCES
Abeti, R., and Abramov, A.Y. (2015). Mitochondrial Ca(2+) in neurodegenera-
tive disorders. Pharmacol. Res. 99, 377–381.
Antony, A.N., Paillard, M., Moffat, C., Juskeviciute, E., Correnti, J., Bolon, B.,
Rubin, E., Csorda´s, G., Seifert, E.L., Hoek, J.B., and Hajno´czky, G. (2016).
MICU1 regulation of mitochondrial Ca(2+) uptake dictates survival and tissue
regeneration. Nat. Commun. 7, 10955.1572 Cell Reports 16, 1561–1573, August 9, 2016Balaban, R.S. (2009). The role of Ca(2+) signaling in the coordination of mito-
chondrial ATP production with cardiac work. Biochim. Biophys. Acta 1787,
1334–1341.
Baughman, J.M., Perocchi, F., Girgis, H.S., Plovanich, M., Belcher-Timme,
C.A., Sancak, Y., Bao, X.R., Strittmatter, L., Goldberger, O., Bogorad, R.L.,
et al. (2011). Integrative genomics identifies MCU as an essential component
of the mitochondrial calcium uniporter. Nature 476, 341–345.
Bhosale, G., Sharpe, J.A., Sundier, S.Y., and Duchen, M.R. (2015). Calcium
signaling as a mediator of cell energy demand and a trigger to cell death.
Ann. N Y Acad. Sci. 1350, 107–116.
Biswas, G., Adebanjo, O.A., Freedman, B.D., Anandatheerthavarada, H.K., Vi-
jayasarathy, C., Zaidi, M., Kotlikoff, M., and Avadhani, N.G. (1999). Retrograde
Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial ge-
netic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO
J. 18, 522–533.
Bo¨hm, J., Chevessier, F., Maues De Paula, A., Koch, C., Attarian, S., Feger, C.,
Hantaı¨, D., Lafore^t, P., Ghorab, K., Vallat, J.M., et al. (2013). Constitutive acti-
vation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am.
J. Hum. Genet. 92, 271–278.
Csorda´s, G., Thomas, A.P., and Hajno´czky, G. (1999). Quasi-synaptic calcium
signal transmission between endoplasmic reticulum and mitochondria. EMBO
J. 18, 96–108.
Csorda´s, G., Va´rnai, P., Golena´r, T., Roy, S., Purkins, G., Schneider, T.G.,
Balla, T., and Hajno´czky, G. (2010). Imaging interorganelle contacts and local
calcium dynamics at the ER-mitochondrial interface. Mol. Cell 39, 121–132.
Csorda´s, G., Golena´r, T., Seifert, E.L., Kamer, K.J., Sancak, Y., Perocchi, F.,
Moffat, C., Weaver, D., de la Fuente Perez, S., Bogorad, R., et al. (2013).
MICU1 controls both the threshold and cooperative activation of the mito-
chondrial Ca2+ uniporter. Cell Metab. 17, 976–987.
de la Fuente, S., Matesanz-Isabel, J., Fonteriz, R.I., Montero, M., and Alvarez,
J. (2014). Dynamics of mitochondrial Ca2+ uptake inMICU1-knockdown cells.
Biochem. J. 458, 33–40.
De Stefani, D., Raffaello, A., Teardo, E., Szabo`, I., and Rizzuto, R. (2011). A
forty-kilodalton protein of the inner membrane is the mitochondrial calcium
uniporter. Nature 476, 336–340.
Deluca, H.F., and Engstrom, G.W. (1961). Calcium uptake by rat kidney mito-
chondria. Proc. Natl. Acad. Sci. USA 47, 1744–1750.
Fieni, F., Lee, S.B., Jan, Y.N., and Kirichok, Y. (2012). Activity of the mitochon-
drial calcium uniporter varies greatly between tissues. Nat. Commun. 3, 1317.
Foskett, J.K., and Philipson, B. (2015). The mitochondrial Ca(2+) uniporter
complex. J. Mol. Cell. Cardiol. 78, 3–8.
Giacomello, M., Drago, I., Bortolozzi, M., Scorzeto, M., Gianelle, A., Pizzo, P.,
and Pozzan, T. (2010). Ca2+ hot spots on the mitochondrial surface are gener-
ated by Ca2+ mobilization from stores, but not by activation of store-operated
Ca2+ channels. Mol. Cell 38, 280–290.
Haynes, C.M., Fiorese, C.J., and Lin, Y.F. (2013). Evaluating and responding to
mitochondrial dysfunction: the mitochondrial unfolded-protein response and
beyond. Trends Cell Biol. 23, 311–318.
Holmstro¨m, K.M., Pan, X., Liu, J.C., Menazza, S., Liu, J., Nguyen, T.T., Pan, H.,
Parks, R.J., Anderson, S., Noguchi, A., et al. (2015). Assessment of cardiac
function in mice lacking the mitochondrial calcium uniporter. J. Mol. Cell. Car-
diol. 85, 178–182.
Kamer, K.J., and Mootha, V.K. (2014). MICU1 and MICU2 play nonredundant
roles in the regulation of the mitochondrial calcium uniporter. EMBO Rep. 15,
299–307.
Kamer, K.J., and Mootha, V.K. (2015). The molecular era of the mitochondrial
calcium uniporter. Nat. Rev. Mol. Cell Biol. 16, 545–553.
Kirichok, Y., Krapivinsky, G., and Clapham, D.E. (2004). The mitochondrial cal-
cium uniporter is a highly selective ion channel. Nature 427, 360–364.
Kova´cs-Bogda´n, E., Sancak, Y., Kamer, K.J., Plovanich, M., Jambhekar, A.,
Huber, R.J., Myre, M.A., Blower, M.D., and Mootha, V.K. (2014). Reconstitu-
tion of the mitochondrial calcium uniporter in yeast. Proc. Natl. Acad. Sci.
USA 111, 8985–8990.
Kwong, J.Q., Lu, X., Correll, R.N., Schwanekamp, J.A., Vagnozzi, R.J., Sar-
gent, M.A., York, A.J., Zhang, J., Bers, D.M., and Molkentin, J.D. (2015). The
Mitochondrial Calcium Uniporter Selectively Matches Metabolic Output to
Acute Contractile Stress in the Heart. Cell Rep. 12, 15–22.
Logan, C.V., Szabadkai, G., Sharpe, J.A., Parry, D.A., Torelli, S., Childs, A.M.,
Kriek, M., Phadke, R., Johnson, C.A., Roberts, N.Y., et al.; UK10K Consortium
(2014). Loss-of-function mutations in MICU1 cause a brain and muscle disor-
der linked to primary alterations inmitochondrial calcium signaling. Nat. Genet.
46, 188–193.
Luongo, T.S., Lambert, J.P., Yuan, A., Zhang, X., Gross, P., Song, J., Shan-
mughapriya, S., Gao, E., Jain, M., Houser, S.R., et al. (2015). TheMitochondrial
Calcium Uniporter Matches Energetic Supply with Cardiac Workload during
Stress and Modulates Permeability Transition. Cell Rep. 12, 23–34.
Mallilankaraman, K., Doonan, P., Ca´rdenas, C., Chandramoorthy, H.C., M€uller,
M., Miller, R., Hoffman, N.E., Gandhirajan, R.K., Molgo´, J., Birnbaum, M.J.,
et al. (2012). MICU1 is an essential gatekeeper for MCU-mediated mitochon-
drial Ca(2+) uptake that regulates cell survival. Cell 151, 630–644.
Martin, S.D., and McGee, S.L. (2014). The role of mitochondria in the aetiology
of insulin resistance and type 2 diabetes. Biochim. Biophys. Acta 1840, 1303–
1312.
Murgia, M., and Rizzuto, R. (2015). Molecular diversity and pleiotropic role of
the mitochondrial calcium uniporter. Cell Calcium 58, 11–17.
Nguyen, T.T., Oh, S.S., Weaver, D., Lewandowska, A., Maxfield, D., Schuler,
M.H., Smith, N.K., Macfarlane, J., Saunders, G., Palmer, C.A., et al. (2014).
Loss of Miro1-directed mitochondrial movement results in a novel murine
model for neuron disease. Proc. Natl. Acad. Sci. USA 111, E3631–E3640.
Nicholson, A., Reifsnyder, P.C., Malcolm, R.D., Lucas, C.A., MacGregor, G.R.,
Zhang, W., and Leiter, E.H. (2010). Diet-induced obesity in two C57BL/6 sub-
strains with intact or mutant nicotinamide nucleotide transhydrogenase (Nnt)
gene. Obesity (Silver Spring) 18, 1902–1905.
Orrenius, S., Zhivotovsky, B., and Nicotera, P. (2003). Regulation of cell death:
the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4, 552–565.
Pan, X., Liu, J., Nguyen, T., Liu, C., Sun, J., Teng, Y., Fergusson, M.M., Rovira,
I.I., Allen, M., Springer, D.A., et al. (2013). The physiological role of mitochon-
drial calcium revealed by mice lacking the mitochondrial calcium uniporter.
Nat. Cell Biol. 15, 1464–1472.
Patron, M., Checchetto, V., Raffaello, A., Teardo, E., Vecellio Reane, D., Man-
toan, M., Granatiero, V., Szabo`, I., De Stefani, D., and Rizzuto, R. (2014).
MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting
opposite effects on MCU activity. Mol. Cell 53, 726–737.
Peng, T.I., and Jou, M.J. (2010). Oxidative stress caused by mitochondrial cal-
cium overload. Ann. N Y Acad. Sci. 1201, 183–188.Perocchi, F., Gohil, V.M., Girgis, H.S., Bao, X.R., McCombs, J.E., Palmer, A.E.,
and Mootha, V.K. (2010). MICU1 encodes a mitochondrial EF hand protein
required for Ca(2+) uptake. Nature 467, 291–296.
Plovanich, M., Bogorad, R.L., Sancak, Y., Kamer, K.J., Strittmatter, L., Li, A.A.,
Girgis, H.S., Kuchimanchi, S., De Groot, J., Speciner, L., et al. (2013). MICU2, a
paralog of MICU1, resides within the mitochondrial uniporter complex to regu-
late calcium handling. PLoS ONE 8, e55785.
Raffaello, A., De Stefani, D., Sabbadin, D., Teardo, E., Merli, G., Picard, A.,
Checchetto, V., Moro, S., Szabo`, I., and Rizzuto, R. (2013). The mitochondrial
calcium uniporter is a multimer that can include a dominant-negative pore-
forming subunit. EMBO J. 32, 2362–2376.
Rasmussen, T.P.,Wu, Y., Joiner, M.L., Koval, O.M.,Wilson, N.R., Luczak, E.D.,
Wang, Q., Chen, B., Gao, Z., Zhu, Z., et al. (2015). Inhibition of MCU forces ex-
tramitochondrial adaptations governing physiological and pathological stress
responses in heart. Proc. Natl. Acad. Sci. USA 112, 9129–9134.
Rizzuto, R., Pinton, P., Carrington, W., Fay, F.S., Fogarty, K.E., Lifshitz, L.M.,
Tuft, R.A., and Pozzan, T. (1998). Close contacts with the endoplasmic reticu-
lum as determinants of mitochondrial Ca2+ responses. Science 280, 1763–
1766.
Sancak, Y., Markhard, A.L., Kitami, T., Kova´cs-Bogda´n, E., Kamer, K.J., Ude-
shi, N.D., Carr, S.A., Chaudhuri, D., Clapham, D.E., Li, A.A., et al. (2013). EMRE
is an essential component of the mitochondrial calcium uniporter complex.
Science 342, 1379–1382.
Santulli, G., Xie, W., Reiken, S.R., and Marks, A.R. (2015). Mitochondrial cal-
cium overload is a key determinant in heart failure. Proc. Natl. Acad. Sci.
USA 112, 11389–11394.
Toye, A.A., Lippiat, J.D., Proks, P., Shimomura, K., Bentley, L., Hugill, A., Mijat,
V., Goldsworthy, M., Moir, L., Haynes, A., et al. (2005). A genetic and physio-
logical study of impaired glucose homeostasis control in C57BL/6J mice. Dia-
betologia 48, 675–686.
Vais, H., Mallilankaraman, K., Mak, D.O., Hoff, H., Payne, R., Tanis, J.E., and
Foskett, J.K. (2016). EMRE Is a Matrix Ca(2+) Sensor that Governs Gate-
keeping of the Mitochondrial Ca(2+) Uniporter. Cell Rep. 14, 403–410.
Vallejo-Illarramendi, A., Toral-Ojeda, I., Aldanondo, G., and Lo´pez de Munain,
A. (2014). Dysregulation of calcium homeostasis in muscular dystrophies.
Expert Rev. Mol. Med. 16, e16.
Vasington, F.D., and Murphy, J.V. (1962). Ca ion uptake by rat kidney mito-
chondria and its dependence on respiration and phosphorylation. J. Biol.
Chem. 237, 2670–2677.
Wang, H., Yang, H., Shivalila, C.S., Dawlaty, M.M., Cheng, A.W., Zhang, F.,
and Jaenisch, R. (2013). One-step generation of mice carrying mutations in
multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153,
910–918.Cell Reports 16, 1561–1573, August 9, 2016 1573
